AT343276B - Verfahren zur herstellung einer antiviral wirksamen pharmazeutischen zusammensetzung - Google Patents

Verfahren zur herstellung einer antiviral wirksamen pharmazeutischen zusammensetzung

Info

Publication number
AT343276B
AT343276B AT207275A AT207275A AT343276B AT 343276 B AT343276 B AT 343276B AT 207275 A AT207275 A AT 207275A AT 207275 A AT207275 A AT 207275A AT 343276 B AT343276 B AT 343276B
Authority
AT
Austria
Prior art keywords
producing
pharmaceutical composition
effective pharmaceutical
antiviral effective
antiviral
Prior art date
Application number
AT207275A
Other languages
English (en)
Other versions
ATA207275A (de
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ATA207275A publication Critical patent/ATA207275A/de
Application granted granted Critical
Publication of AT343276B publication Critical patent/AT343276B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT207275A 1975-02-13 1975-03-18 Verfahren zur herstellung einer antiviral wirksamen pharmazeutischen zusammensetzung AT343276B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6173/75A GB1530912A (en) 1975-02-13 1975-02-13 Compositions containing 9-(2-hydroxy-3-alkyl)-adenines

Publications (2)

Publication Number Publication Date
ATA207275A ATA207275A (de) 1977-09-15
AT343276B true AT343276B (de) 1978-05-26

Family

ID=9809759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT207275A AT343276B (de) 1975-02-13 1975-03-18 Verfahren zur herstellung einer antiviral wirksamen pharmazeutischen zusammensetzung

Country Status (10)

Country Link
US (1) US4315920A (de)
AT (1) AT343276B (de)
BE (1) BE826935A (de)
CA (1) CA1054521A (de)
DE (1) DE2512609A1 (de)
GB (1) GB1530912A (de)
IN (1) IN141900B (de)
NZ (1) NZ176971A (de)
ZA (1) ZA751650B (de)
ZM (1) ZM5975A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
DE3323621A1 (de) * 1982-07-08 1984-03-01 Yamasa Shoyu K.K., Choshi, Chiba Pharmazeutisches praeparat mit die antitumor-wirkung verstaerkender wirkung, ein solches praeparat enthaltende chemotherapeutische zusammensetzung und verwendung des praeparates zur unterstuetzung der antitumor-behandlung beim menschen und tier
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
EP0871449A1 (de) * 1996-02-12 1998-10-21 Cypros Pharmaceutical Corporation Hydroxynonyladenin analoge mit verbesserten lipophilen und antiischämischen eigenschaften
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6579857B1 (en) 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
WO2002004452A2 (en) 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives

Also Published As

Publication number Publication date
US4315920A (en) 1982-02-16
ZM5975A1 (en) 1977-01-21
ZA751650B (en) 1976-10-27
ATA207275A (de) 1977-09-15
NZ176971A (en) 1984-07-31
CA1054521A (en) 1979-05-15
GB1530912A (en) 1978-11-01
BE826935A (fr) 1975-09-22
DE2512609A1 (de) 1976-08-26
AU7934275A (en) 1976-09-23
IN141900B (de) 1977-04-30

Similar Documents

Publication Publication Date Title
AT360654B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
AT362782B (de) Verfahren zur herstellung von 4-hydroxypyrrolidin-2-on-derivaten
DD127902A5 (de) Verfahren zur herstellung von mercaptoazetidin-derivaten
AT362781B (de) Verfahren zur herstellung von 4-hydroxypyrrolidin-2-on-derivaten
AT343276B (de) Verfahren zur herstellung einer antiviral wirksamen pharmazeutischen zusammensetzung
AT367295B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
AT358572B (de) Verfahren zur herstellung von 5-aroyl-1- niederalkyl-pyrrol-2-essigsaeure-derivaten
AT361140B (de) Verfahren zur herstellung optisch aktiver 11- -desoxy-16-aryloxy-omega-tetranorprostaglandine
DD128590A5 (de) Verfahren zur herstellung optisch aktiver 11-desoxy-16-aryl-omega-tetranorprostaglandine
AT369987B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT348499B (de) Verfahren zur herstellung von aethylchlorthioformiat
AT363174B (de) Verfahren zur herstellung von pharmazeutischen zubereitungen
AT361639B (de) Verfahren zur herstellung von 5-androsten-17- -on-derivaten
AT355725B (de) Verfahren zur herstellung stabiler loesungen
AT350582B (de) Verfahren zur herstellung von n-mehtyl-harn- stoffen
ATA310976A (de) Verfahren zur herstellung von pepropionsaeure
ATA311076A (de) Verfahren zur herstellung einer perpropionsaurelosung
AT366695B (de) Verfahren zur herstellung von 3-brommethyl-3cephemsulfoxydderivaten
AT363625B (de) Verfahren zur herstellung von 21-hydroxy-20methyl-pregnan-derivaten
AT376633B (de) Verfahren zur herstellung von phosphornitriden
PT64875B (de) Verfahren zur herstellung von n-alenyl-2-aminomethyl-pyrrolidinen
AT368500B (de) Verfahren zur herstellung von ergolin-derivaten
DD127762A5 (de) Verfahren zur herstellung von azetamidoximderivaten
DD134423A3 (de) Verfahren zur herstellung farbloser bleimolybdat-einkristalle
DD131467A1 (de) Verfahren zur kontinuierlichen herstellung von acyltauriden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties